Discovery Laboratories, Inc. (DSCO) - Financial and Strategic SWOT Analysis Review

GlobalData, March 2013, Pages: 41

Summary

Discovery Laboratories, Inc. (Discovery Laboratories) is a specialty biotechnology company. It develops life saving products for critical patients with respiratory diseases particularly pulmonary medicine. The company develops Surfactant Replacement Therapies (SRTs) for treating respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), acute respiratory failure (ARF) and acute lung injury (ALI).

Discovery Laboratories, Inc. Key Recent Developments

Mar 13, 2013: Discovery Labs Reports 2012 Results
Jan 04, 2013: Discovery Labs Appoints John Cooper As CEO
Nov 08, 2012: Discovery Labs Reports Q3 2012 Results
Aug 02, 2012: Discovery Labs Reports Q2 2012 Results
Jul 18, 2012: Discovery Labs Receives US Patent For Method To Promote Mucus Clearance With Pulmonary Surfactant

This comprehensive SWOT profile of Discovery Laboratories, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

List of Tables
List of Figures
Section 1 - About the Company
Discovery Laboratories, Inc. - Key Facts
Discovery Laboratories, Inc. - Key Employees
Discovery Laboratories, Inc. - Key Employee Biographies
Discovery Laboratories, Inc. - Major Products and Services
Discovery Laboratories, Inc. - Pharmaceutical Pipeline Products Data
Discovery Laboratories, Inc., Pipeline Products by Therapy Area
Discovery Laboratories, Inc., Pipeline Products by Development Phase
Discovery Laboratories, Inc. - History
Discovery Laboratories, Inc. - Company Statement
Discovery Laboratories, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Discovery Laboratories, Inc. - Business Description
Discovery Laboratories, Inc. - SWOT Analysis
SWOT Analysis - Overview
Discovery Laboratories, Inc. - Strengths
Strength - Strong Research and Development Capabilities
Strength - Lead Product Candidate: Surfaxin
Strength - Strategic Agreements
Discovery Laboratories, Inc. - Weaknesses
Weakness - Working Capital Deficit
Weakness - Limited Liquidity
Discovery Laboratories, Inc. - Opportunities
Opportunity - Product Pipeline
Opportunity - Changing Demographics
Opportunity - Emerging Markets
Discovery Laboratories, Inc. - Threats
Threat - Government Regulations
Threat - Intense Competition
Threat - Uncertain R&D Outcomes
Discovery Laboratories, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Discovery Laboratories, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Discovery Laboratories, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Discovery Laboratories, Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Discovery Laboratories, Inc., Recent Developments
Mar 13, 2013: Discovery Labs Reports 2012 Results
Jan 04, 2013: Discovery Labs Appoints John Cooper As CEO
Nov 08, 2012: Discovery Labs Reports Q3 2012 Results
Aug 02, 2012: Discovery Labs Reports Q2 2012 Results
Jul 18, 2012: Discovery Labs Receives US Patent For Method To Promote Mucus Clearance With Pulmonary Surfactant
Jun 21, 2012: Discovery Labs To Be Added To Russell 2000 And Russell Global Indexes
May 03, 2012: Discovery Labs Reports Q1 2012 Results
Mar 29, 2012: Discovery Labs Reports Q4 2011 Results
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Discovery Laboratories, Inc., Key Facts
Discovery Laboratories, Inc., Key Employees
Discovery Laboratories, Inc., Key Employee Biographies
Discovery Laboratories, Inc., Major Products and Services
Discovery Laboratories, Inc., Number of Pipeline Products by Therapy Area
Discovery Laboratories, Inc., Number of Pipeline Products by Development Stage
Discovery Laboratories, Inc., Pipeline Products By Therapy Area and Development Phase
Discovery Laboratories, Inc., History
Discovery Laboratories, Inc., Other Locations
Discovery Laboratories, Inc., Subsidiaries
Discovery Laboratories, Inc., Key Competitors
Discovery Laboratories, Inc., Ratios based on current share price
Discovery Laboratories, Inc., Annual Ratios
Discovery Laboratories, Inc., Interim Ratios
Discovery Laboratories, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Discovery Laboratories, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Discovery Laboratories, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Discovery Laboratories, Inc., Pipeline Products by Therapy Area
Discovery Laboratories, Inc., Pipeline Products by Development Phase
Discovery Laboratories, Inc., Performance Chart (2007 - 2011)
Discovery Laboratories, Inc., Ratio Charts
Discovery Laboratories, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Discovery Laboratories, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013

Dey Pharma, L.P.
Forest Laboratories, Inc.
GlaxoSmithKline plc
Chiesi Farmaceutici SpA

Customers who bought this item also bought

• Charter Schools - Global Outlook
• eLEARNING - Global Strategic Business Report
• Aerospace and Defense Industry - Global Strategic Business Report
• Sports and Fitness Nutrition - Global Strategic Business Report
• Education Services - Global Strategic Business Report
• North America – Smart Weapons Markets and Technologies Outlook – 2013-2020
• Commercial And Military Flight Simulation - Global Strategic Business Report
• International Military and Civilian Unmanned Aerial Vehicle Survey
• Private Tutoring - Global Strategic Business Report
• The Future of the Biodefense Industry: Regulation, Funding Opportunities & Company Profiles